NxStage Medical Inc (NASDAQ:NXTM)

18.20
Delayed Data
As of Apr 17
 -0.10 / -0.55%
Today’s Change
10.69
Today|||52-Week Range
19.19
+1.51%
Year-to-Date

Today’s Trading

Previous close18.30
Today’s open18.15
Day’s range17.83 - 18.22
Volume249,991
Average volume (3 months)399,013
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-25.81%
Earnings growth (this year)+4.17%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.45%
P/E ratioNM
Price/Sales3.67
Price/Book6.02

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...-1.02-6.57%
KERXKeryx Biopharmaceuti...-0.83-6.76%
BRLIBio-Reference Labora...-0.30-0.86%
DBVTDBV Technologies SA-0.45-1.77%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$301.5M
Annual profit (last year)-$23.9M
Net profit margin-7.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Jeffrey H. Burbank
Senior Vice President-
Manufacturing Operations
Thomas F. Shea
Corporate headquarters
Lawrence, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers